Trial intelligence / Profile preview

Acarbose for Postprandial Hypotension in Older Adults with Type 2 Diabetes

NCT02043886Phase 2Completed

Sponsor
University of British Columbia
Start
Jun 2007
Primary completion
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Postprandial hypotension (PPH) comparing Acarbose with Placebo (2 arms). Primary endpoints: Heart rate, Blood pressure and 5 more. Started Jun 2007; status: completed.

02

Drugs

acarbose
03

Conditions

Postprandial hypotension (PPH)

Beyond the preview

Go deeper on NCT02043886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02043886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call